Caladrius Announces Changes to Its Board of Directors
BASKING RIDGE, N.J., Dec. 23, 2015 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (“Caladrius” or the “Company”) (NASDAQ:CLBS), a cell therapy company combining an industry-leading development and manufacturing services provider with a therapeutic …